Orthofix Medical Inc.
NASDAQ:OFIXMedical - Devices
+$0.03 today
- Market cap
- $269.42M
- Beta
- 0.71
- P/E (TTM)
- -6.2
- EPS (TTM)
- -$1.48
Volume 0.40M
Average 0.38M
OFIX Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Orthofix Medical Inc.NASDAQ: OFIX
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization dips below year-ago levels
Q1 FY2026 depreciation & amortization of $13.49M fell 62.2% year over year, behind the +42.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 84.9% from the prior quarter. Over 3 fiscal years it compounded at +16.7% a year.
Context
- Depreciation & amortization amounted to 6.2% of revenue in FY2025, down 1.3 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -62.2% toward the trailing-twelve-month pace of +42.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 50.97M USD
- Year-over-year change
- -15.1%
- 4-year CAGR
- +11.4%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 50.97M | -15.1% |
| FY2024 | 2024-12-31 | 60.06M | -0.8% |
| FY2023 | 2023-12-31 | 60.56M | +88.8% |
| FY2022 | 2022-12-31 | 32.08M | -3.1% |
| FY2021 | 2021-12-31 | 33.1M | — |
Depreciation & Amortization vs competitors
How OFIX compares with its peers on the latest reported figures
- OFIX's LTM Mar 2026 depreciation & amortization of $135.37M is the highest of the 11 companies compared; the peer median is $7.84M.
- Its year-over-year change of +42.0% is the 3rd highest of 11, against a peer median of -11.1%.
- Depreciation & amortization amounts to 16.4% of revenue for OFIX, versus a peer median of 7.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $135.37M | +42.0% | +16.7% | 16.4% | |
| LTM Mar 2026 | $39.5M | -9.6% | -11.0% | 5.5% | |
| LTM Apr 2026 | $27.1M | -0.7% | -6.8% | 3.2% | |
| LTM Mar 2026 | $17.69M | -95.7% | +207.8% | 11.1% | |
| LTM Mar 2026 | $11.4M | -12.6% | -3.4% | 620.8% | |
| LTM Mar 2026 | $8.15M | +78.5% | -7.6% | 4.0% | |
| LTM Mar 2026 | $7.53M | -25.6% | +10.8% | 7.3% | |
| LTM Mar 2026 | $6.29M | -60.3% | -22.5% | 7.3% | |
| LTM Mar 2026 | $3.08M | +50.1% | +151.3% | — | |
| LTM Mar 2026 | $2.1M | -71.5% | -9.0% | 9.9% | |
| LTM Mar 2026 | $106K | +19.1% | -40.6% | 0.0% | |
| Peer median (excluding OFIX) | $7.84M | -11.1% | -7.2% | 7.3% | |
Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 464.48M | 460.71M | 746.64M | 799.49M | 822.31M |
| Cost of Revenue | 114.91M | 123.54M | 260.37M | 253.61M | 270.61M |
| Gross Profit | 349.57M | 337.17M | 486.27M | 545.89M | 551.71M |
| Gross Margin | 75.3% | 73.2% | 65.1% | 68.3% | 67.1% |
| Research & Development | 49.62M | 49.07M | 80.23M | 73.64M | 57.11M |
| Selling, General & Admin | 290.67M | 308.78M | 530.4M | 532.53M | 456.39M |
| Operating Expenses | 357.88M | 350.44M | 625.38M | 630.5M | 620.18M |
| Depreciation & Amortization | 33.1M | 32.08M | 60.56M | 60.06M | 50.97M |
| EBITDA | 21.44M | 15.66M | (79.49M) | (34.18M) | (22.35M) |
| EBITDA Margin | 4.6% | 3.4% | -10.6% | -4.3% | -2.7% |
| Operating Income | (8.32M) | (13.27M) | (139.11M) | (84.62M) | (68.47M) |
| Operating Margin | -1.8% | -2.9% | -18.6% | -10.6% | -8.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.84M | 1.29M | 8.63M | 29.63M | 17.49M |
| Other Income / Expenses | (5.18M) | (4.44M) | (9.57M) | (39.26M) | (22.34M) |
| Income Before Tax | (13.5M) | (17.71M) | (148.68M) | (123.88M) | (90.81M) |
| Pre-Tax Margin | -2.9% | -3.8% | -19.9% | -15.5% | -11.0% |
| Income Tax Expense | 24.88M | 2.04M | 2.72M | 2.12M | 1.38M |
| Net Income | (38.38M) | (19.75M) | (151.4M) | (126M) | (92.19M) |
| Net Margin | -8.3% | -4.3% | -20.3% | -15.8% | -11.2% |
| EPS (Basic) | (1.95) | (0.98) | (4.12) | (3.30) | (2.28) |
| EPS (Diluted) | (1.95) | (0.98) | (4.12) | (3.30) | (2.28) |
| Weighted Avg Shares | 19.69M | 20.1M | 36.73M | 38.13M | 39.88M |
| Weighted Avg Shares (Diluted) | 19.69M | 20.1M | 36.73M | 38.13M | 39.88M |
Orthofix Medical Inc.
NASDAQ:OFIX
Intrinsic Alpha fair value
Locked
Current Price
$6.61
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.